BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15811093)

  • 1. Successful treatment of chronic actinic dermatitis with topical pimecrolimus.
    Larangeira de Almeida H
    Int J Dermatol; 2005 Apr; 44(4):343-4. PubMed ID: 15811093
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of chronic actinic dermatitis treated with topical tacrolimus.
    Baldo A; Prizio E; Mansueto G; Somma P; Monfrecola G
    J Dermatolog Treat; 2005; 16(4):245-8. PubMed ID: 16249148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial actinic lichen planus following the Blaschko's lines: successful treatment with topical 0.1% pimecrolimus cream.
    Ezzedine K; Simonart T; Vereecken P; Heenen M
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):458-9. PubMed ID: 18624870
    [No Abstract]   [Full Text] [Related]  

  • 4. [Topical tacrolimus in chronic actinic dermatitis].
    Girault PY; Boye T; Veran Y
    Ann Dermatol Venereol; 2008 Oct; 135(10):688-90. PubMed ID: 18929923
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus.
    Evans AV; Palmer RA; Hawk JL
    Photodermatol Photoimmunol Photomed; 2004 Feb; 20(1):59-61. PubMed ID: 14738535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream.
    Segura S; Romero D; Carrera C; Iranzo P; Estrach T
    Acta Derm Venereol; 2005; 85(6):524-5. PubMed ID: 16396803
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of oral lichen planus with topical pimecrolimus 1% cream.
    Esquivel-Pedraza L; Fernández-Cuevas L; Ortíz-Pedroza G; Reyes-Gutiérrez E; Orozco-Topete R
    Br J Dermatol; 2004 Apr; 150(4):771-3. PubMed ID: 15099380
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%.
    Bellini V; Simonetti S; Lisi P
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):113-5. PubMed ID: 18181988
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of cheilitis glandularis superimposed on oral lichen planus: successful palliative treatment with topical tacrolimus and pimecrolimus.
    Erkek E; Sahin S; Kilic R; Erdogan S
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):999-1000. PubMed ID: 17659026
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of Zoon's balanitis with topical tacrolimus.
    Hague J; Ilchyshyn A
    Int J Dermatol; 2006 Oct; 45(10):1251-2. PubMed ID: 17040458
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic actinic dermatitis: treatment with topical tacrolimus (two cases)].
    Alquier-Bouffard A; Da Costa CM; Roger H; Franck F; Taïeb A; Souteyrand P; D'incan M
    Ann Dermatol Venereol; 2007; 134(6-7):555-8. PubMed ID: 17657183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.
    Schneeweiss S; Doherty M; Zhu S; Funch D; Schlienger RG; Fernandez-Vidaurre C; Seeger JD
    Dermatology; 2009; 219(1):7-21. PubMed ID: 19293564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The successful use of topical tacrolimus treatment for a chronic actinic dermatitis patient with complications of idiopathic leukopenia.
    Ogawa Y; Adachi A; Tomita Y
    J Dermatol; 2003 Nov; 30(11):805-9. PubMed ID: 14684938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molluscum contagiosum infection associated with pimecrolimus use in pityriasis alba.
    Goksugur N; Ozbostanci B; Goksugur SB
    Pediatr Dermatol; 2007; 24(5):E63-5. PubMed ID: 17958783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of pimecrolimus and tacrolimus to skin and plasma proteins: implications for systemic exposure after topical application.
    Weiss HM; Fresneau M; Moenius T; Stuetz A; Billich A
    Drug Metab Dispos; 2008 Sep; 36(9):1812-8. PubMed ID: 18524871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
    Hartmann A; Bröcker EB; Hamm H
    J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical pimecrolimus in the treatment of vitiligo.
    Boone B; Ongenae K; Van Geel N; Vernijns S; De Keyser S; Naeyaert JM
    Eur J Dermatol; 2007; 17(1):55-61. PubMed ID: 17324829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B.
    Campione E; Paternò EJ; Diluvio L; Bianchi L; Giorgetti G; Chimenti S
    Acta Derm Venereol; 2008; 88(1):74-5. PubMed ID: 18176762
    [No Abstract]   [Full Text] [Related]  

  • 20. Pimecrolimus and tacrolimus: the US FDA public health advisory.
    Maddin S
    Skin Therapy Lett; 2005 May; 10(4):1-3. PubMed ID: 15986080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.